Aquestive therapeutics to report second quarter 2023 financial results and recent business highlights on august 7 and host conference call on august 8 at 8:00 a.m. et

Warren, n.j., july 25, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), (the “company” or “aquestive”), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for the second quarter ended june 30, 2023, and provide an update on recent developments in its business after market close on monday, august 7, 2023.
AQST Ratings Summary
AQST Quant Ranking